Assessment of drug susceptibility by nucleic acid sequencing of a patient's hepatitis C virus (HCV) to the NS5A inhibitors. Assay should be used for patients with documented HCV genotype 1.
Indicate the patient's HCV genotype (1a or 1b) on the test request form.
Polymerase chain reaction (PCR) amplification and DNA next generation sequencing
An interpretive report will be provided